A/Prof Qingwei Luo
@qingweiluo.bsky.social
Associate Professor, The Daffodil Centre, The University of Sydney, and Cancer Council NSW
We’re thrilled to have our linked comment published in @thelancet.com
The future of cancer control depends on decisive, collective action today.
🔗 Read it here: doi.org/10.1016/S014...
📄 Original article: doi.org/10.1016/S014...
@daffodilcentre.org
@sydney.edu.au
The future of cancer control depends on decisive, collective action today.
🔗 Read it here: doi.org/10.1016/S014...
📄 Original article: doi.org/10.1016/S014...
@daffodilcentre.org
@sydney.edu.au
September 26, 2025 at 4:12 AM
We’re thrilled to have our linked comment published in @thelancet.com
The future of cancer control depends on decisive, collective action today.
🔗 Read it here: doi.org/10.1016/S014...
📄 Original article: doi.org/10.1016/S014...
@daffodilcentre.org
@sydney.edu.au
The future of cancer control depends on decisive, collective action today.
🔗 Read it here: doi.org/10.1016/S014...
📄 Original article: doi.org/10.1016/S014...
@daffodilcentre.org
@sydney.edu.au
Reposted by A/Prof Qingwei Luo
NEW RESEARCH🔬| We are excited to share the first long-term projections for cancer prevalence linked to key pan-tumour biomarkers in Australia.
🔍This study aims to inform health policy and healthcare planning for targeted therapies.
🌐Read the full article🔗 doi.org/10.1016/j.la...
🔍This study aims to inform health policy and healthcare planning for targeted therapies.
🌐Read the full article🔗 doi.org/10.1016/j.la...
April 8, 2025 at 2:34 AM
NEW RESEARCH🔬| We are excited to share the first long-term projections for cancer prevalence linked to key pan-tumour biomarkers in Australia.
🔍This study aims to inform health policy and healthcare planning for targeted therapies.
🌐Read the full article🔗 doi.org/10.1016/j.la...
🔍This study aims to inform health policy and healthcare planning for targeted therapies.
🌐Read the full article🔗 doi.org/10.1016/j.la...
Reposted by A/Prof Qingwei Luo
🆕 First long-term #projections for #cancer prevalence associated with key #PanTumour #biomarkers in #Australia to 2042, to inform health policy & planning for targeted therapies.
#MedSky #OncSky @daffodilcentre.bsky.social
@juliasteinberg.bsky.social @qingweiluo.bsky.social
🔗Check out full text!
#MedSky #OncSky @daffodilcentre.bsky.social
@juliasteinberg.bsky.social @qingweiluo.bsky.social
🔗Check out full text!
Informing health system planning for biomarker-based treatment: statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042
We present the first long-term projections for cancer prevalence associated with key
pan-tumour biomarkers in Australia, to inform health policy and healthcare planning
for targeted therapies.
www.thelancet.com
April 7, 2025 at 4:29 AM
🆕 First long-term #projections for #cancer prevalence associated with key #PanTumour #biomarkers in #Australia to 2042, to inform health policy & planning for targeted therapies.
#MedSky #OncSky @daffodilcentre.bsky.social
@juliasteinberg.bsky.social @qingweiluo.bsky.social
🔗Check out full text!
#MedSky #OncSky @daffodilcentre.bsky.social
@juliasteinberg.bsky.social @qingweiluo.bsky.social
🔗Check out full text!
Reposted by A/Prof Qingwei Luo
NEW RESEARCH🔬| This pilot, randomised waitlist-controlled trial aimed to evaluate the feasibility, acceptability, and safety of #iConquerFear, a self-guided online fear of cancer recurrence intervention for #OvarianCancer survivors.
🌐Read the full article🔗 doi.org/10.1186/s128...
🌐Read the full article🔗 doi.org/10.1186/s128...
April 1, 2025 at 5:40 AM
NEW RESEARCH🔬| This pilot, randomised waitlist-controlled trial aimed to evaluate the feasibility, acceptability, and safety of #iConquerFear, a self-guided online fear of cancer recurrence intervention for #OvarianCancer survivors.
🌐Read the full article🔗 doi.org/10.1186/s128...
🌐Read the full article🔗 doi.org/10.1186/s128...